Faculty Opinions recommendation of Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.

2016 ◽  
Author(s):  
Philip Rosenthal
Keyword(s):  
Hepatitis C Virus ◽  
Liver Disease ◽  
Hepatitis C ◽  
Virus Infection ◽  
Phase 2 ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Open Label ◽  
Advanced Liver Disease ◽  
Phase 2 Trial

scholarly journals Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial

2016 ◽  
Vol 151 (5) ◽  
pp. 893-901.e1 ◽  
Author(s):  
Eric Lawitz ◽  
Nancy Reau ◽  
Federico Hinestrosa ◽  
Mordechai Rabinovitz ◽  
Eugene Schiff ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Phase 2 ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

scholarly journals Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection

2010 ◽  
Vol 71 (8) ◽  
pp. 829-832 ◽  
Author(s):  
Elizabeth J. Ryan ◽  
Megan Dring ◽  
Cliona M. Ryan ◽  
Carol McNulty ◽  
Nigel J. Stevenson ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Liver Disease ◽  
Hepatitis C ◽  
Virus Infection ◽  
Chronic Hepatitis C ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus
Sign in / Sign up

Export Citation Format

Share Document